More Globe Newswire

View Older Stories View Newer Stories

Feb 27, 2024 09:00AM Automated Cybersecurity Platform OP[4] Appoints Veteran Intelligence Analyst Daniel Velasquez Executive Vice President
Feb 27, 2024 09:00AM Consumers Pressing Pause on Major Kitchen and Bath Retail Spending in Favor of Do-It-Yourself Improvements, Reports Circana
Feb 27, 2024 09:00AM Extending the Driving Range without Increasing EV Weight? Yes, Solidion Technology, Inc. Provides Solutions
Feb 27, 2024 09:00AM Finix Expands Payments Offering into Canadian Market, Accelerating International Availability
Feb 27, 2024 09:00AM Imprivata launches new Biometric Patient Identity solution to protect patient privacy and address misidentification crisis
Feb 27, 2024 09:00AM Beckley Academy Publishes First Open-Source Learning Framework to Advance Psychedelic-Assisted Therapy Training Standards
Feb 27, 2024 09:00AM Riot Purchases 31,500 Miners From MicroBT to Enhance and Expand Self-Mining Operations at Its Rockdale Facility
Feb 27, 2024 09:00AM FreeWire Ushers New Era of EV Charging & Energy Management with Launch of Boost Power Pro
Feb 27, 2024 09:00AM New Fluent Survey of Retailers and Brands Measures Commerce Media Strategies and Challenges
Feb 27, 2024 09:00AM New Pushpay Study Reveals Increased Technology Adoption Among Catholic Churches—Hybrid Worship, Mobile Giving, and Digital Security are Top Priorities
Feb 27, 2024 09:00AM IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESEN
Feb 27, 2024 09:00AM Virtu Financial Announces Strategic Collaboration with ClearingBid to Expand ClearingBid’s Platform for Primary Share IPO Investing
Feb 27, 2024 09:00AM SEALSQ’s Root Certificate Authority Accredited by GSMA Participates in the Worldwide Roll-out of the Latest eUICC Consumer Specifications, Facilitating Security and Interoperability
Feb 27, 2024 09:00AM Carrolton Facility Management Achieves Efficiencies with Corcentric’s Managed Accounts Payable and Payments Solutions
Feb 27, 2024 09:00AM Varonis Named to CRN’s 2024 Security 100 List
Feb 27, 2024 09:00AM True Tickets Partners with the Paramount & State Theatres in Austin, TX to Elevate Moontower Just For Laughs Austin Comedy Festival Ticketing Experience
Feb 27, 2024 09:00AM Accruent Amplifies Cloud Collaboration with Microsoft to Accelerate Business Productivity
Feb 27, 2024 09:00AM Capitol Benefits, LLC Partners with Applied to Unify Technology Strategy Across its P&C and Benefits Business
Feb 27, 2024 09:00AM Fogo de Chão Expands in Maryland with Restaurant in Towson Town Center
Feb 27, 2024 08:59AM Havila Shipping ASA: Fourth quarter 2023 accounts
Feb 27, 2024 09:00AM Amber Therapeutics announces positive preliminary results from its first-in-human investigation of Amber-UI, its new adaptive implanted pudendal neuromodulation system for urinary incontinence
Feb 27, 2024 09:00AM Estrel Berlin sets a new sustainability standard for the hotel & event industry
Feb 27, 2024 08:59AM Fareportal Online Travel Agency Brands Launch Travel Briefs Series
Feb 27, 2024 08:56AM Abacus Life (ABL) Officially Launches Technology Sub-Division – ABL Tech
Feb 27, 2024 08:45AM Gulf Island Announces Sale of Excess Property
Feb 27, 2024 08:45AM International Myeloma Foundation (IMF) Launches #MyelomaActionMonth for 2024 March Myeloma Action Month
Feb 27, 2024 08:44AM Hunton Andrews Kurth Welcomes Travis G. Hill, Former CEO of Virginia ABC Authority, to Global Economic Development, Commerce, and Government Relations Team
Feb 27, 2024 08:40AM Blackstone Completes Acquisition of Rover
Feb 27, 2024 08:40AM AITX’s RAD Begins Production Run of 1000 Next Generation RIO Solar-Powered Security Towers
Feb 27, 2024 08:38AM Safety Shot Appoints New CFO Danielle De Rosa
Feb 27, 2024 08:35AM VAALCO Response to Media Speculation
Feb 27, 2024 08:35AM Biom Pharmaceutical Published Clinical Safety & Efficacy of VagiBiom® Microbiome-based Probiotic Suppositories for Intimate Women's Health
Feb 27, 2024 08:35AM Biom Pharmaceutical Published Clinical Safety & Efficacy of VagiBiom® Microbiome-based Probiotic Suppositories for Intimate Women's Health
Feb 27, 2024 08:33AM Form 8.3 - Smart Metering Systems plc
Feb 27, 2024 08:33AM EXL named a Leader in Everest Group Payment Integrity Solutions PEAK Matrix® Assessment 2024
Feb 27, 2024 08:31AM Ibogaine by David Dardashti Optimizes Algorithm for Fentanyl Treatment
Feb 27, 2024 08:31AM Consolidated Water Declares Second Quarter Cash Dividend
Feb 27, 2024 08:30AM Form 8.3 - LXI REIT PLC
Feb 27, 2024 08:30AM Capricor Therapeutics Announces Upcoming Type-B Meeting with the FDA to Discuss Commercial Manufacturing Planning with an Aim to Expedite BLA Pathway for CAP-1002 in Duchenne Muscular Dystrophy
Feb 27, 2024 08:30AM RB Capital Partners, Inc. Officially Moves Forward with Appointment of a Receiver for Optec International, Inc.
Feb 27, 2024 08:30AM Auddia Signs Purchase Agreement to Acquire Radio FM; Advancing M&A User Acquisition Strategy
Feb 27, 2024 08:30AM Riverlane and Rigetti Computing Partner with Oak Ridge National Laboratory to Work to Improve HPC-Quantum Integration
Feb 27, 2024 08:30AM Driivz Appoints Blake Jessen as new Vice President of North America
Feb 27, 2024 08:30AM Cerevance Announces Presentation at AD/PD™ 2024 International Conference
Feb 27, 2024 08:30AM Patriot Glass Solutions, a Subsidiary of C-Bond Systems, Receives a Prestigious Dealer of the Year Award from Eastman Performance Films
Feb 27, 2024 08:30AM Roper Technologies to present at Morgan Stanley technology conference
Feb 27, 2024 08:30AM Silynxcom Delivers $280,000 Repeat Order from Military Customer
Feb 27, 2024 08:30AM ABVC's New Horizon for Oncology and Hematology Aims at Cancer Market of Several Hundred Billion Dollars
Feb 27, 2024 08:30AM Manuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients with Heart Failure and Hyperinflammation Published in European Journal of Heart Failure
Feb 27, 2024 08:30AM Memorial Sloan Kettering Cancer Center Now Enrolling Patients in Phase 1/2 Clinical Trial of IMUNON’s IMNN-001 in Combination with Bevacizumab in Advanced Ovarian Cancer
View Newer Stories View Older Stories